New report singles out Big Pharma players for ringing their blockbusters with patents while hiking prices for years
What do Roche, Pfizer and AbbVie all have in common, aside from sharing Big Pharma status?
They all have pursued a strategy of padding their …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
